Achieve Life Sciences Reports Financial Results for First Quarter 2023 and Provides Corporate Update
May 09, 2023 16:05 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 09, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences to Announce First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 9, 2023
April 26, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Global Nicotine Gum Market Report 2023: Sector is Expected to Reach $2 Billion by 2030 at a CAGR of 5.6%
April 24, 2023 13:43 ET
|
Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Nicotine Gum Market Size, Share & Trends Analysis Report By Type (2mg, 4mg), By Distribution Channel (Supermarkets/Hypermarkets, Convenience...
Achieve Life Sciences Announces Positive Phase 2 ORCA-V1 Trial Results Showing Statistically Significant Vaping Cessation Benefit for Participants Treated with Cytisinicline
April 20, 2023 08:00 ET
|
Achieve Life Sciences
First Randomized, Placebo-Controlled Clinical Study to Report Successful E-Cigarette Cessation Benefit with Pharmacological Treatment Study Supports Potential Broad Utilization of Cytisinicline for...
Achieve Life Sciences to Present at Life Science Innovation Northwest 2023 Conference
April 14, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 14, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Refresh to Board of Directors
March 30, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 30, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
March 29, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...
$53.87 Billion Smoking Cessation & Nicotine De-Addiction Product Markets - Global Forecast 2023-2030
March 24, 2023 08:43 ET
|
Research and Markets
Dublin, March 24, 2023 (GLOBE NEWSWIRE) -- The "Smoking Cessation & Nicotine De-Addiction Product Market Research Report by Product (Drug Therapy, E-Cigarettes, and Nicotine Inhalers),...
Patient Centric Healthcare App Global Market Report 2023: Sector to Reach $32.4 Billion by 2028 at a 20.8% CAGR
March 22, 2023 08:28 ET
|
Research and Markets
Dublin, March 22, 2023 (GLOBE NEWSWIRE) -- The "Patient Centric Healthcare App Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Achieve Life Sciences Announces Granting of New Hire Inducement Award
March 17, 2023 08:00 ET
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...